Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.
The company today said it proposes offer for sale of $250 million of shares.
DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.
Source: Read Full Article
Lates News:
-
Intuitive Machines Adds 7% On Successful Test Run Of Nova-C Lunar Lander
-
Bitcoin Sits On Critical Support As Ethereum Tackles Sub $1,500 Bears
-
$BTC: US Space Force Major’s Book Highlights Bitcoin’s Significance for National Security
-
Partnership With Bitcoin Giant NYDIG Will Enable New York Yankees Employees to Convert Salaries To BTC
-
AngloGold Ashanti Adds 6% On Decision To Invest $$$ In G2 Goldfields